Related Experiment Videos
[Molecular basis of urea cycle disorders]
I Matsuda1, T Matsuura, R Hoshide
1Department of Pediatrics, Kumamoto University School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|February 1, 1993
Summary
Urea cycle enzyme deficiencies, including carbamyl phosphate synthetase I and ornithine transcarbamylase, show highly diverse genetic alleles. This genetic heterogeneity contrasts sharply with other metabolic disorders like cystic fibrosis.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Context:
- Urea synthesis is crucial for ammonia detoxification, involving five key enzymes: carbamyl phosphate synthetase I (CPS I), ornithine transcarbamylase (OTC), argininosuccinate synthetase (AS), argininosuccinate lyase (AL), and arginase (AR).
- The genetic underpinnings of deficiencies in these urea cycle enzymes are increasingly understood with clarified cDNA and genomic DNA structures for several enzymes.
Purpose:
- To investigate the allelic heterogeneity in deficiencies of the five urea cycle enzymes.
- To compare the genetic diversity of urea cycle disorders with other inborn errors of metabolism.
Summary:
- Genetic analysis has identified alleles for deficiencies in CPS I, OTC, AS, AL, and AR.
- These urea cycle enzyme deficiencies exhibit extreme allelic heterogeneity.
- This contrasts significantly with the genetic landscape of conditions like cystic fibrosis and hemoglobinopathies.
Impact:
- Understanding the genetic basis of urea cycle disorders is vital for diagnosis and potential therapeutic strategies.
- The high degree of allelic heterogeneity presents unique challenges for genetic screening and treatment development.
- This research highlights a distinct genetic characteristic of urea cycle disorders within the spectrum of inborn errors of metabolism.